146 related articles for article (PubMed ID: 27926644)
21. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening among vulnerable women: factors affecting guideline adherence at a community health centre in Toronto, Ont.
Wiedmeyer ML; Lofters A; Rashid M
Can Fam Physician; 2012 Sep; 58(9):e521-6. PubMed ID: 22972744
[TBL] [Abstract][Full Text] [Related]
24. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups.
Flores EJ; López D; Miles RC; Glover M; Lehman CD; Harvey HB; Narayan AK
J Am Coll Radiol; 2019 Jul; 16(7):908-914. PubMed ID: 30737162
[TBL] [Abstract][Full Text] [Related]
25. State Medicaid expansion decisions and disparities in women's cancer screening.
Sabik LM; Tarazi WW; Bradley CJ
Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
[TBL] [Abstract][Full Text] [Related]
26. Screening with Papanicolaou tests in Alberta: Are we Choosing Wisely?
Symonds CJ; Chen W; Rose MS; Cooke LJ
Can Fam Physician; 2018 Jan; 64(1):47-53. PubMed ID: 29358254
[TBL] [Abstract][Full Text] [Related]
27. Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
Mills JM; Morgan JR; Dhaliwal A; Perkins RB
Gynecol Oncol; 2021 Aug; 162(2):308-314. PubMed ID: 34090706
[TBL] [Abstract][Full Text] [Related]
28. Discontent and Confusion: Primary Care Providers' Opinions and Understanding of Current Cervical Cancer Screening Recommendations.
Boone E; Lewis L; Karp M
J Womens Health (Larchmt); 2016 Mar; 25(3):255-62. PubMed ID: 26540622
[TBL] [Abstract][Full Text] [Related]
29. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
30. Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests?
Bartley SJ; Benard V; Tai E; Rockwell T; Kenney K; Richardson LC
Prev Med; 2020 Jun; 135():106078. PubMed ID: 32247009
[TBL] [Abstract][Full Text] [Related]
31. Disparities of National Lung Cancer Screening Guidelines in the US Population.
Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK
J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195
[TBL] [Abstract][Full Text] [Related]
32. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.
Meissner HI; Tiro JA; Yabroff KR; Haggstrom DA; Coughlin SS
Med Care; 2010 Mar; 48(3):249-59. PubMed ID: 20182268
[TBL] [Abstract][Full Text] [Related]
33. Adherence to Cervical Cancer Screening Guidelines Among Women Aged 66-68 Years in a Large Community-Based Practice.
Chao CR; Xu L; Lonky NM
Am J Prev Med; 2019 Dec; 57(6):757-764. PubMed ID: 31753257
[TBL] [Abstract][Full Text] [Related]
34. Differences in Cervical Cancer Screening Between African-American Versus African-Born Black Women in the United States.
Forney-Gorman A; Kozhimannil KB
J Immigr Minor Health; 2016 Dec; 18(6):1371-1377. PubMed ID: 26349483
[TBL] [Abstract][Full Text] [Related]
35. Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
Wright JD; Chen L; Tergas AI; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL
JAMA Netw Open; 2021 Apr; 4(4):e218373. PubMed ID: 33914050
[TBL] [Abstract][Full Text] [Related]
36. Sociodemographic predictors of adherence to annual cervical cancer screening in minority women.
Jennings-Dozier K; Lawrence D
Cancer Nurs; 2000 Oct; 23(5):350-6; quiz 357-8. PubMed ID: 11037955
[TBL] [Abstract][Full Text] [Related]
37. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
38. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
39. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study.
Teoh DG; Marriott AE; Isaksson Vogel R; Marriott RT; Lais CW; Downs LS; Kulasingam SL
Am J Obstet Gynecol; 2015 Jan; 212(1):62.e1-9. PubMed ID: 24992692
[TBL] [Abstract][Full Text] [Related]
40. Individual, provider, and system risk factors for breast and cervical cancer screening among underserved Black, Latina, and Arab women.
Roman L; Meghea C; Ford S; Penner L; Hamade H; Estes T; Williams KP
J Womens Health (Larchmt); 2014 Jan; 23(1):57-64. PubMed ID: 24283674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
